RAP 0.00% 20.5¢ raptor resources limited

This pfizers and resmeds of the world could leverage billions...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 42 Posts.
    lightbulb Created with Sketch. 94
    This pfizers and resmeds of the world could leverage billions off of this tech and associated IP.

    I tried to undertake an at home sleep study recently with a company that may or may not have been mentioned above.

    My experience was an absolute failure:

    Walk into company > get refered to doctor
    Go to doctor to get referral for sleep study (govt. funded)
    Call company to arrange appointment
    Attend appointment > be provided with sleep study pack
    Try to work WTF to attach and where
    After 45 mins & big rise in cortisol levels, try to sleep
    Don't sleep for 3 hrs due to cortisol levels & discomfort
    Pull this numerous wires off and spit the dummy
    Drop kit back in the morning on the way to work
    Vow to put the fork down and loose some weight

    Said company lose a customer through no real fault of their own.

    Govt. funded sleep study wasted...

    I understand that diagnosis of sleep disorders is more complicated and nuanced than just sleep apnoea, but surely resapps underlying algorithm(s) could be embedded within a wireless sensor and microphone based diagnostic platform which is much more patient centric and ultimately effective.

    Cost savings for govt. to be had & many, many more customers / billions in revenue for industry.

    Current SP still shows no respect to the scale and opportunity that could be leveraged from Resapps tech and IP.

    Would hate to be the employees in M&A at Pfizer if they screw this up.

    STILL A STRONG NO FOR ME!

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.